AR and metabolic syndrome: The studies in animals and in men after androgen deprivation therapy which suppress functions of androgen/androgen receptor (AR) signaling revealed significant metabolic disorders like T2DM and MetS which can be associated with tissue-specific AR signaling that is involved in regulation of metabolism [32].